[go: up one dir, main page]

BR0214299A - Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo - Google Patents

Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo

Info

Publication number
BR0214299A
BR0214299A BR0214299-6A BR0214299A BR0214299A BR 0214299 A BR0214299 A BR 0214299A BR 0214299 A BR0214299 A BR 0214299A BR 0214299 A BR0214299 A BR 0214299A
Authority
BR
Brazil
Prior art keywords
peptide
converting enzyme
enzyme inhibitor
angiotensin converting
hypotensive agent
Prior art date
Application number
BR0214299-6A
Other languages
English (en)
Inventor
Akio Yamada
Hitoshi Saito
Yasushi Kawaguchi
Eri Inoue
Hiroshi Ochi
Tomoko Ide
Yoshitaka Tamura
Hiroshi Miyakawa
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19167543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0214299(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of BR0214299A publication Critical patent/BR0214299A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"PEPTìDEO, INIBIDOR DE ENZIMA DE CONVERSãO DE ANGIOTENSINA., E, AGENTE HIPOTENSIVO". Um peptídeo Met-Lys-Pro, que é obtido por síntese química ou hidrólise de caseína, é usado como o ingrediente ativo de inibidores de angiotensina convertase ou drogas hipotensivas.
BR0214299-6A 2001-11-21 2002-11-21 Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo BR0214299A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001355923 2001-11-21
PCT/JP2002/012197 WO2003044044A1 (en) 2001-11-21 2002-11-21 Novel peptide having angiotensin convertase inhibitory effect

Publications (1)

Publication Number Publication Date
BR0214299A true BR0214299A (pt) 2004-12-14

Family

ID=19167543

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214299-6A BR0214299A (pt) 2001-11-21 2002-11-21 Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo

Country Status (18)

Country Link
US (1) US7022676B2 (pt)
EP (1) EP1457498B9 (pt)
JP (1) JP3816921B2 (pt)
KR (1) KR100615844B1 (pt)
CN (1) CN1240711C (pt)
AT (1) ATE353336T1 (pt)
AU (1) AU2002366037B2 (pt)
BR (1) BR0214299A (pt)
CA (1) CA2468039C (pt)
CY (1) CY1106557T1 (pt)
DE (1) DE60218064T2 (pt)
DK (1) DK1457498T3 (pt)
ES (1) ES2281567T3 (pt)
MX (1) MXPA04004805A (pt)
NO (1) NO328611B1 (pt)
NZ (1) NZ533544A (pt)
PT (1) PT1457498E (pt)
WO (1) WO2003044044A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000878A (es) * 2003-08-01 2006-03-30 Calpis Co Ltd Hidrolizado de caseina, proceso para producirla y uso de la misma.
CA2549185C (en) * 2003-12-01 2012-10-30 Meiji Dairies Corporation Peptide inhibiting angiotensin converting enzyme
CN100503633C (zh) * 2004-12-29 2009-06-24 山东大学 中国毛虾蛋白降压肽及其制备方法与应用
CN102304169B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压多肽及其用途
CN102276690B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压功能性多肽及其用途
WO2013125622A1 (ja) * 2012-02-22 2013-08-29 森永乳業株式会社 ジペプチジルペプチダーゼ－ｉｖ阻害剤
CN104159912B (zh) 2012-03-09 2016-11-09 森永乳业株式会社 二肽基肽酶iv 抑制剂
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
JP6344796B2 (ja) * 2014-09-30 2018-06-20 森永乳業株式会社 高齢者用アルツハイマー型認知症改善剤
JP2018057346A (ja) * 2016-10-07 2018-04-12 森永乳業株式会社 カゼイン酵素処理物及びその製造方法
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
WO2019058609A1 (ja) 2017-09-19 2019-03-28 森永乳業株式会社 エネルギー消費促進用組成物
JP2019142791A (ja) * 2018-02-16 2019-08-29 森永乳業株式会社 血圧降下用及び／又は中性脂肪低減用の組成物
EP3753569A4 (en) * 2018-02-16 2021-12-15 Morinaga Milk Industry Co., Ltd. COMPOSITION FOR LOWERING BLOOD PRESSURE AND / OR FOR LOWERING NEUTRAL FATS
JP6589011B2 (ja) * 2018-05-17 2019-10-09 森永乳業株式会社 脳機能障害改善用経口組成物
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07313185A (ja) 1992-08-20 1995-12-05 Marino Forum 21 ぺプチドの製造方法
JP3040389B2 (ja) 1999-01-18 2000-05-15 日本合成化学工業株式会社 ペプチドの製造法

Also Published As

Publication number Publication date
CN1612892A (zh) 2005-05-04
JPWO2003044044A1 (ja) 2005-03-10
KR100615844B1 (ko) 2006-08-25
EP1457498A4 (en) 2005-10-19
US7022676B2 (en) 2006-04-04
NZ533544A (en) 2005-02-25
KR20050044541A (ko) 2005-05-12
US20050004041A1 (en) 2005-01-06
WO2003044044A1 (en) 2003-05-30
DE60218064T2 (de) 2007-11-15
AU2002366037A1 (en) 2003-06-10
JP3816921B2 (ja) 2006-08-30
DK1457498T3 (da) 2007-06-04
EP1457498B1 (en) 2007-02-07
CY1106557T1 (el) 2012-01-25
HK1076114A1 (en) 2006-01-06
CA2468039A1 (en) 2003-05-30
CN1240711C (zh) 2006-02-08
ATE353336T1 (de) 2007-02-15
CA2468039C (en) 2011-01-04
NO20042601L (no) 2004-08-18
ES2281567T3 (es) 2007-10-01
PT1457498E (pt) 2007-05-31
NO328611B1 (no) 2010-03-29
EP1457498A1 (en) 2004-09-15
MXPA04004805A (es) 2004-08-11
AU2002366037B2 (en) 2005-11-03
EP1457498B9 (en) 2009-09-02
DE60218064D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
BR0214299A (pt) Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo
ATE328995T1 (de) Kontrolliertes wirkstoffabgabesystem
BR9908280A (pt) Inibidores de enzimas de fosfolipase
BR0317715A (pt) Composições e processos de uso de collajolie
MXPA03011006A (es) Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos.
DE60041761D1 (de) Tribonektine
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
PL360092A1 (en) Structures and compositions increasing the stability of peroxide actives
BR0108471A (pt) Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente
BRPI0602329A (pt) composição de cuidados orais, dispositivos e métodos de uso das mesmas
HK1052553A1 (zh) 膠原酶的溶液和晶格及其使用
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
AR031782A1 (es) Dentifrico de astringencia reducida, que contiene zinc
EP1435899A4 (en) COMPOSITION FOR PROMOTING HAIR GROWTH
BR0312683A (pt) Cápsulas de higiene oral
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
BR9903257A (pt) Concentrado de suspensão aquosa contendo tiadiazurona e etefona
ATE342004T1 (de) Operationswerkzeug
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
NO20021856D0 (no) Koplingsdal
DE50310091D1 (de) Parfümierte Reinigungsmittelformkörper
TR199902423T2 (xx) Antiviral proteaz inhibit�rleri
FI972605A0 (fi) Myrsyraloesning med saenkt korroderande verkan
BR0112460A (pt) Método para tratamento de sépsis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.